Further, we found that MTL-CEBPA abrogates the immune suppressive activity of TAMs and MDSCs in this syngeneic mouse model enabling CD8 T cell-driven anti-tumor activity, indicating that MTL-CEBPA removes the immunosuppressive breaks required for ICI action on CD8 T cells.20 This evidence concerns the gene CD8A and neoplasm.